DEA schedule
Is scopolamine a controlled substance?
Federal schedule for scopolamine from the FDA NDC directory, checked against the DEA controlled substances list.
Source: FDA NDC Directory file dated 2026-10-22. Publisher page
No. Scopolamine is not a federally controlled substance. None of its FDA NDC listings carries a DEA schedule, and scopolamine is not on the DEA controlled substances list.
Run it in Rivvi
Which 2027 plans near you dropped or restricted scopolamine?
Tier changes and new prior auth, step therapy or quantity limits, plan by plan.
Free to start. Opens Rivvi, the AI workspace for healthcare teams.
Schedule check
| Source | What it lists |
|---|---|
| FDA NDC directory | 22 prescription listings from 12 labelers, none with a DEA schedule |
| DEA controlled substances list | scopolamine is not on the list |
Scopolamine NDC listings
| NDC | Product | Form | Strength | Labeler | DEA schedule |
|---|---|---|---|---|---|
| 10019-008 | Transderm Scop | patch, extended release | 1 mg/3d | Baxter Healthcare Corporation | None |
| 0378-6470 | Scopolamine | patch | 1 mg/3d | Mylan Pharmaceuticals Inc. | None |
| 50090-5349 | Scopolamine | patch | 1 mg/3d | A-S Medication Solutions | None |
| 42858-150 | Scopolamine | patch, extended release | 1 mg/3d | Rhodes Pharmaceuticals LLC | None |
| 50090-8154 | Scopolamine | patch, extended release | 1 mg/3d | A-S Medication Solutions | None |
| 69238-1662 | Scopolamine | patch, extended release | 1 mg/3d | Amneal Pharmaceuticals NY LLC | None |
| 70710-1846 | Scopolamine | patch, extended release | 1 mg/3d | Zydus Pharmaceuticals USA Inc. | None |
| 70771-1787 | Scopolamine | patch, extended release | 1 mg/3d | Zydus Lifesciences Limited | None |
| 71335-3013 | Scopolamine | patch, extended release | 1 mg/3d | Bryant Ranch Prepack | None |
| 71335-3014 | Scopolamine | patch, extended release | 1 mg/3d | Bryant Ranch Prepack | None |
| 71335-3015 | Scopolamine | patch, extended release | 1 mg/3d | Bryant Ranch Prepack | None |
| 72162-2453 | Scopolamine | patch, extended release | 1 mg/3d | Bryant Ranch Prepack | None |
| 50742-505 | Scopolamine | patch, extended release | 1.5 mg/1 | Ingenus Pharmaceuticals, LLC | None |
| 68071-3994 | Scopolamine | patch, extended release | 1.5 mg/1 | NuCare Pharmaceuticals, Inc. | None |
| 0591-2258 | scopolamine | system | 1 mg/3d | Actavis Pharma, Inc. | None |
| 50090-7188 | scopolamine | system | 1 mg/3d | A-S Medication Solutions | None |
| 63629-8450 | Scopolamine Trandermal System | patch, extended release | 1 mg/1 | Bryant Ranch Prepack | None |
| 63629-8451 | Scopolamine Trandermal System | patch, extended release | 1 mg/1 | Bryant Ranch Prepack | None |
| 63629-8452 | Scopolamine Trandermal System | patch, extended release | 1 mg/1 | Bryant Ranch Prepack | None |
| 72162-1419 | Scopolamine Trandermal System | patch, extended release | 1 mg/1 | Bryant Ranch Prepack | None |
| 45802-580 | Scopolamine Transdermal System | patch, extended release | 1 mg/1 | Padagis Israel Pharmaceuticals Ltd | None |
| 71335-2718 | Scopolamine Transdermal System | patch, extended release | 1 mg/1 | Bryant Ranch Prepack | None |
Questions
Is scopolamine a controlled substance?
No. Scopolamine is not a federally controlled substance. None of its FDA NDC listings carries a DEA schedule, and scopolamine is not on the DEA controlled substances list.
Is scopolamine a narcotic?
No. Scopolamine is not on the DEA controlled substances list, so the DEA does not classify it as a narcotic. Its FDA established pharmacologic class is Anticholinergic.
Does this page cover state schedules?
No. This page reports the federal schedule only. Some states schedule drugs on their own; check your state board of pharmacy.